Dihydroergotamine suppositories in a headache clinic.
Dihydroergotamine (DHE) is available in the United States for parenteral use. We report a preliminary trial of DHE suppositories in an outpatient headache clinic setting. Dihydroergotamine suppositories may be appropriate for patients with catamenial migraine and classic migraine in particular.
Ward
T N
TN
Dartmouth Medical School, Hanover, New Hampshire.
Scott
G
G
D004087:Dihydroergotamine / Q000008:administration & dosage* / Q000009:adverse effects; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D013488:Suppositories
D013488:Suppositories; D004087:Dihydroergotamine